ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 690271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 690271; 2) Community: the network communities that were significantly associated with the response to NSC 690271; 3) Molecule: the relationships between components within communities and NSC 690271; 4) MDR: the compounds that were significantly associated with the NSC 690271.

NSC Compound Enrichment Correlation
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.000141616984257996 0.43671229
NSC 734758 Null 0.000141616984257997 0.27857934
NSC 682506 Methanone, 3-(chloromethyl)-2,3-dihydro-6-(dimethylamino)- 1H-indol-1-yl-5,6,7-trimethoxy-1H-indol-2-yl- 0.000150163566228975 0.59819193
NSC 698131 Null 0.000150163566228977 0.55043491
NSC 691247 Null 0.000166573147098354 0.35479709
NSC 268993 Deferoxamine hydrochloride 0.000174252554411806 0.36607735
NSC 33530 Null 0.000176661849797006 0.3870004
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.000176661849797006 0.48028389
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.000176661849797006 0.55867525
NSC 610456 Camptothecin Derivative 0.000284051704014449 0.58510435
Total:100  Current:1    [First] [Prev] [Next] [Last]